Academic publishers face class action over ‘peer review’ pay, other restrictions
By Mike Scarcella
Sept 13 (Reuters) -A University of California Los Angeles neuroscience professor has sued six major academic journal publishers, claiming in a proposed class action that they violated antitrust law by barring simultaneous submissions to multiple journals and denying pay for “peer review” services.
Professor Lucina Uddin filed the lawsuit in Brooklyn federal court on Thursday against Elsevier, John Wiley & Sons, Sage Publications, Springer Nature, Taylor & Francis and Wolters Kluwer.
Scholarly journal submissions are reviewed by other experts in the author's field to vet their submissions for publication and comment on their findings. Uddin said that the practice of not paying scholars for peer reviews amounted to unlawful price-fixing.
The lawsuit also said the publishers unlawfully agreed not to compete with each other for manuscripts, reducing any incentive to review and publish work more quickly.
Wiley in a statement said the claims "are without merit." Wolters Kluwer, Elsevier and the other defendants declined to comment or did not immediately respond to a request for one.
Dean Harvey, a lawyer for Uddin, said in a statement that the for-profit academic publishing industry had earned billions "exploiting the goodwill and hard work of brilliant scholars, and of taxpayers who foot the bill to create their product.”
The lawsuit said the publishing defendants in 2023 collectively received more than $10 billion in revenue from their peer-reviewed journals.
Uddin has been a professor in UCLA’s psychology department since July 2023. Her complaint said she has published more than 175 academic articles and provided peer review services for more than 150 journals.
The lawsuit seeks class-action status for an estimated “hundreds of thousands” of class members.
"It has become increasingly difficult to coerce busy scholars into providing their valuable labor for nothing,” Uddin said, and manuscripts can sit awaiting peer review for months or years.
Her lawsuit also challenged what it called a “gag” rule that bars scholars from freely sharing scientific advancements in their manuscripts while they are under peer review.
Scholars often must sign away intellectual property rights to their work in exchange for nothing, the lawsuit said, while the publishers charge “the maximum the market will bear for access to that scientific knowledge.”
The case is Dr. Lucina Uddin v. Elsevier BV et al, U.S. District Court for the Eastern District of New York, No. 1:24-cv-06409.
For plaintiffs: Dean Harvey of Lieff Cabraser Heimann & Bernstein, and Benjamin Elga of Justice Catalyst Law
For defendants: No appearances yet
Mga Kaugnay na Asset
Pinakabagong Balita
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.
